T cell antigen receptor recognition of antigen-presenting molecules

Annual Review of Immunology

Volumn 33, Issue , 2015, Pages 169-200

  Rossjohn, Jamie ^a,b   Gras, Stephanie ^a   Miles, John J ^b,c   Turner, Stephen J ^d   Godfrey, Dale I ^d   McCluskey, James ^d  

^a MONASH UNIVERSITY   (Australia)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CD1; Major histocompatibility complex; MR1; T cell antigen receptor

Indexed keywords

ALPHA BETA T LYMPHOCYTE RECEPTOR; CD1D ANTIGEN; GAMMA DELTA T LYMPHOCYTE RECEPTOR; LIPID; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BINDING;

ALLOIMMUNITY; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL STRUCTURE; CROSS REACTION; GENETIC POLYMORPHISM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTIGEN PRESENTATION; CHEMISTRY; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; CROSS REACTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LIPIDS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL;

EID: 84927661328     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032414-112334     Document Type: Article

References (150)

1. van der Merwe PA, Dushek O. 2011. Mechanisms for T cell receptor triggering. Nat. Rev. Immunol. 11:47-55
2. BharadwajM, Illing P,Theodossis A, Purcell AW, Rossjohn J,McCluskey J. 2012. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex. Annu. Rev. Pharmacol. Toxicol. 52:401-31
3. Yin Y, Li Y, Mariuzza RA. 2012. Structural basis for self-recognition by autoimmune T-cell receptors. Immunol. Rev. 250:32-48
4. Zinkernagel RM, Doherty PC. 1997. The discovery of MHC restriction. Immunol. Today 18:14-17
5. Brigl M, Brenner MB. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-90
6. Birkinshaw RW, Kjer-Nielsen L, Eckle SB, McCluskey J, Rossjohn J. 2014. MAITs, MR1 and vitamin B metabolites. Curr. Opin. Immunol. 26C:7-13
7. Luoma AM, Castro CD, Mayassi T, Bembinster LA, Bai L, et al. 2013. Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. Immunity 39:1032-42
8. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-41
9. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, et al. 1996. An αβ T cell receptor structure at 2.5A and its orientation in the TCR-MHC complex. Science 274:209-19
10. Rudolph MG, Stanfield RL, Wilson IA. 2006. How TCRs bindMHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24:419-66
11. Yin L, Scott-Browne J, Kappler JW, Gapin L, Marrack P. 2012. T cells and their eons-old obsession with MHC. Immunol. Rev. 250:49-60
12. Burrows SR, Chen Z, Archbold JK, Tynan FE, Beddoe T, et al. 2010. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. PNAS 107:10608-13
13. Garcia KC, Adams JJ, Feng D, Ely LK. 2009. The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat. Immunol. 10:143-47
14. Felix NJ, Allen PM. 2007. Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 7:942-53
15. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI. 2012. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12:845-57
16. Adams EJ, Luoma AM. 2013. The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Annu. Rev. Immunol. 31:529-61
17. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, et al. 2010. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. PNAS 107:5534-39
18. Rodgers JR, Cook RG. 2005. MHC class Ib molecules bridge innate and acquired immunity. Nat. Rev. Immunol. 5:459-71
19. Girardi E, Zajonc DM. 2012. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunol. Rev. 250:167-79
20. Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402
21. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. 1999. A direct estimate of the human αβT cell receptor diversity. Science 286:958-61
22. Garcia KC, Degano M, Pease LR, HuangM, Peterson PA, et al. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166-72
23. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK. 2012. Structural and biophysical determinants of αβT-cell antigen recognition. Immunology 135:9-18
24. Gras S, Burrows SR, Kjer-Nielsen L, Clements CS, Liu YC, et al. 2009. The shaping of T cell receptor recognition by self-tolerance. Immunity 30:193-203
25. Turner SJ, Doherty PC,McCluskey J, Rossjohn J. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6:883-94
26. Birnbaum ME, Mendoza JL, Sethi DK, Dong S, Glanville J, et al. 2014. Deconstructing the peptide-MHC specificity of T cell recognition. Cell 157:1073-87
27. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. 2012. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Immunol. Rev. 250:61-81
28. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW. 2008. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu. Rev. Immunol. 26:171-203
29. Kjer-Nielsen L, Clements CS, Purcell AW, Brooks AG, Whisstock JC, et al. 2003. A structural basis for the selection of dominant αβT cell receptors in antiviral immunity. Immunity 18:53-64
30. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY. 2003. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4:657-63
31. Gras S, Saulquin X, Reiser J-B, Debeaupuis E, Echasserieau K, et al. 2009. Structural bases for the affinity-driven selection of a publicTCRagainst a dominant human cytomegalovirus epitope. J. Immunol. 183:430-37
32. Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, et al. 2005. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat. Immunol. 6:1114-22
33. Tynan FE, Reid HH, Kjer-Nielsen L,Miles JJ, Wilce MC, et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class Imolecule. Nat. Immunol. 8:268-76
34. Ladell K, HashimotoM, Iglesias MC,Wilmann PG, McLaren JE, et al. 2013. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38:425-36
35. Borg NA, Ely LK, Beddoe T, Macdonald WA, Reid HH, et al. 2005. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition. Nat. Immunol. 6:171-80
36. Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, Fontes MR, et al. 2002. The structure of HLAB8 complexed to an immunodominant viral determinant: peptide-induced conformational changes and a mode of MHC class I dimerization. J. Immunol. 169:5153-60
37. Kjer-Nielsen L, Clements CS, Brooks AG, Purcell AW, McCluskey J, Rossjohn J. 2002. The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. Structure 10:1521-32
38. Ely LK, Beddoe T, Clements CS, Matthews JM, Purcell AW, et al. 2006. Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. PNAS 103:6641-46
39. Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael AJ, Jones EY. 2008. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vβ domain. Immunity 28:171-82
40. Motozono C, Kuse N, Sun X, Rizkallah PJ, Fuller A, et al. 2014. Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B∗51:01. J. Immunol. 192:3428-34
41. Miles JJ, Bulek AM, Cole DK, Gostick E, Schauenburg AJ, et al. 2010. Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection. PLoS Pathog. 6:e1001198
42. Cole DK, Yuan F, Rizkallah PJ, Miles JJ, Gostick E, et al. 2009. Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor. J. Biol. Chem. 284:27281-89
43. Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, et al. 2009. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206:209-19
44. Stewart-Jones GB, Simpson P, van derMerwe PA, Easterbrook P, McMichael AJ, et al. 2012. Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. PNAS 109:E3483-92
45. Luz JG, Huang M, Garcia KC, Rudolph MG, Apostolopoulos V, et al. 2002. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing Vβinteractions. J. Exp. Med. 195:1175-86
46. Miles JJ, Elhassen D, Borg NA, Silins SL, Tynan FE, et al. 2005. CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol. 175:3826-34
47. Liu YC, Chen Z, Burrows SR, Purcell AW,McCluskey J, et al. 2012. The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule. J. Biol. Chem. 287:12267-76
48. Macdonald WA, Purcell AW,MifsudNA, Ely LK, Williams DS, et al. 2003. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198:679-91
49. Archbold JK, Macdonald WA, Gras S, Ely LK, Miles JJ, et al. 2009. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J. Exp. Med. 206:209-19
50. Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, et al. 2010. Allelic polymorphism in the T cell receptor and its impact on immune responses. J. Exp. Med. 207:1555-67
51. LiuYC, Chen Z, NellerMA, Miles JJ, PurcellAW,et al. 2014.Amolecular basis for the interplay between T cells, viral mutants, and human leukocyte antigen micropolymorphism. J. Biol. Chem. 289:16688-98
52. Hoare HL, Sullivan LC, Pietra G, Clements CS, Lee EJ, et al. 2006. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat. Immunol. 7:256-64
53. Walpole NG, Kjer-Nielsen L, Kostenko L, McCluskey J, Brooks AG, et al. 2010. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J. Mol. Biol. 397:467-80
54. Chen J-L, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, et al. 2005. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J. Exp. Med. 201:1243-55
55. Bulek AM, Cole DK, Skowera A, Dolton G, Gras S, et al. 2012. Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetes. Nat. Immunol. 13:283-89
56. Speir JA, Stevens J, Joly E, Butcher GW, Wilson IA. 2001. Two different, highly exposed, bulged structures for an unusually long peptide bound to rat MHC class I RT1-Aa. Immunity 14:81-92
57. Borbulevych OY, Piepenbrink KH, Gloor BE, Scott DR, Sommese RF, et al. 2009. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31:885-96
58. Degano M, Garcia KC, Apostolopoulos V, Rudolph MG, Teyton L,Wilson IA. 2000. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12:251-61
59. Ding Y-H, Baker BM, Garboczi DN, BiddisonWE, Wiley DC. 1999. Four A6-TCR/Peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11:45-56
60. Baker BM, Gagnon SJ, BiddisonWE, WileyDC. 2000. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. Immunity 13:475-84
61. Luz JG, Huang M, Garcia KC, Rudolph MG, Apostolopoulos V, et al. 2002. Structural comparison of allogenic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing Vβinteractions. J. Exp. Med. 195:1175-86
62. Reiser JB, Darnault C, Gregoire C, Mosser T, Mazza G, et al. 2003. CDR3 loop flexibility contributes to the degeneracy of TCR recognition. Nat. Immunol. 4:241-47
63. Reiser JB, Darnault C, Guimezanes A, Gregoire C, Mosser T, et al. 2000. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat. Immunol. 1:291-97
64. Reiser JB, Gregoire C, Darnault C, Mosser T, Guimezanes A, et al. 2002. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345-54
65. Borbulevych OY, Insaidoo FK, Baxter TK, Powell DJ Jr, Johnson LA, et al. 2007. Structures of MART-126/27-35 peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J. Mol. Biol. 372:1123-36
66. Borbulevych OY, Santhanagopolan SM,Hossain M, Baker BM. 2011. TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. J. Immunol. 187:2453-63
67. Insaidoo FK, Borbulevych OY, Hossain M, Santhanagopolan SM, Baxter TK, Baker BM. 2011. Loss of T cell antigen recognition arising from changes in peptide andmajor histocompatibility complex protein flexibility: implications for vaccine design. J. Biol. Chem. 286:40163-73
68. Ding YH, Smith KJ,Garboczi DN,Utz U, BiddisonWE, WileyDC. 1998. Two humanTcell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403-11
69. Gras S, Wilmann PG, Chen Z, Halim H, Liu YC, et al. 2012. A structural basis for varied αβTCR usage against an immunodominant EBV antigen restricted to a HLA-B8 molecule. J. Immunol. 188:311-21
70. Liu YC, Miles JJ, NellerMA, Gostick E, Price DA, et al. 2013. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J. Biol. Chem. 288:15442-54
71. Shimizu A, Kawana-Tachikawa A, Yamagata A,Han C, ZhuD, et al. 2013. Structure ofTCRand antigen complexes at an immunodominant CTL epitope in HIV-1 infection. Sci. Rep. 3:3097
72. Colf LA, Bankovich AJ, Hanick NA, Bowerman NA, Jones LL, et al. 2007. How a single T cell receptor recognizes both self and foreign MHC. Cell 129:135-46
73. MacdonaldWA,ChenZ,Gras S,Archbold JK, Tynan FE, et al. 2009.Tcell allorecognition via molecular mimicry. Immunity 31:897-908
74. Bowerman NA, Colf LA, Garcia KC, Kranz DM. 2009. Different strategies adopted by Kb and Ld to generate T cell specificity directed against their respective bound peptides. J. Biol. Chem. 284:32551-61
75. Reinherz EL, Tan K, Tang L, Kern P, Liu J, et al. 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286:1913-21
76. Feng D, Bond CJ, Ely LK, Maynard J, Garcia KC. 2007. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon.' Nat. Immunol. 8:975-83
77. Dai S, Huseby ES, Rubtsova K, Scott-Browne J, Crawford F, et al. 2008. Crossreactive T cells spotlight the germline rules for αβT cell-receptor interactions with MHC molecules. Immunity 28:324-34
78. Garcia KC. 2012. Reconciling views onTcell receptor germline bias forMHC. Trends Immunol. 33:429-36
79. Dai S, Crawford F, Marrack P, Kappler JW. 2008. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. PNAS 105:11893-97
80. Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, et al. 2011. T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity 35:681-93
81. Mazza C, Auphan-Anezin N, Gregoire C, Guimezanes A, Kellenberger C, et al. 2007. How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides? EMBO J. 26:1972-83
82. Deng L, Langley RJ, Wang Q, Topalian SL, Mariuzza RA. 2012. Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3. PNAS 109:14960-65
83. Deng L, Langley RJ, Brown PH, Xu G, Teng L, et al. 2007. Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nat. Immunol. 8:398-408
84. Miles JJ, Borg NA, Brennan RM, Tynan FE, Kjer-Nielsen L, et al. 2006. TCRα genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J. Immunol. 177:6804-14
85. Broughton SE, Petersen J, Theodossis A, Scally SW, Loh KL, et al. 2012. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity 37:611-21
86. Hahn M, NicholsonMJ, Pyrdol J, Wucherpfennig KW. 2005. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6:490-96
87. HarkiolakiM, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, et al. 2009. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30:348-57
88. Hennecke J, Carfi A,WileyDC. 2000. Structure of a covalently stabilized complex of a human αβT-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19:5611-24
89. Maynard J, Petersson K,Wilson DH, Adams EJ, Blondelle SE, et al. 2005. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22:81-92
90. He XL, Radu C, Sidney J, Sette A, Ward ES, Garcia KC. 2002. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 17:83-94
91. Yin Y, Li Y, Kerzic MC, Martin R, Mariuzza RA. 2011. Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection. EMBO J. 30:1137-48
92. Garcia KC, Radu CG, Ho J, Ober RJ, Ward ES. 2001. Kinetics and thermodynamics of T cell receptorautoantigen interactions in murine experimental autoimmune encephalomyelitis. PNAS 98:6818-23
93. Sewell AK. 2012. Why must T cells be cross-reactive? Nat. Rev. Immunol. 12:669-77
94. Sethi DK, Schubert DA, Anders A-K, Heroux A, Bonsor DA, et al. 2011. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J. Exp. Med. 208:91-102
95. Sethi DK, Gordo S, Schubert DA, Wucherpfennig KW. 2013. Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop. Nat. Commun. 4:2623
96. Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. 2005. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24:2968-79
97. Petersen J, Montserrat V, Mujico JR, Loh KL, Beringer DX, et al. 2014. T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease. Nat. Struct. Mol. Biol. 21:480-88
98. ClaytonG,Kappler J. 2014. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell 158:1-11
99. Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, et al. 2012. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486:554-58
100. Stadinski BD, Trenh P, Smith RL, Bautista B, Huseby PG, et al. 2011. A role for differential variable gene pairing in creating T cell receptors specific for unique major histocompatibility ligands. Immunity 35:694-704
101. Borg NA,Wun KS,Kjer-NielsenL,WilceMC,Pellicci DG, et al. 2007. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448:44-49
102. Wun KS, Borg NA, Kjer-Nielsen L, Beddoe T, Koh R, et al. 2008. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J. Exp. Med. 205:939-49
103. Scott-Browne JP, Matsuda JL, Mallevaey T, White J, Borg NA, et al. 2007. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 8:1105-13
104. Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, et al. 2009. Differential recognition of CD1d-α-galactosyl ceramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors. Immunity 31:47-59
105. Patel O, Pellicci DG, Uldrich AP, Sullivan LC, Bhati M, et al. 2011. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen. PNAS 108:19007-12
106. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, et al. 2011. A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killerTcells with distinct glycolipid antigen-recognition properties. Nat. Immunol. 12:616-23
107. Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, et al. 2011. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315-26
108. López-Sagaseta J, Kung JE, Savage PB, Gumperz J, Adams EJ. 2012. Themolecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor. PLOS Biol. 10:e1001412
109. Pellicci DG, Clarke AJ, Patel O, Mallevaey T, Beddoe T, et al. 2011. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat. Immunol. 12:827-33
110. Yu ED, Girardi E, Wang J, Zajonc DM. 2011. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. J. Immunol. 187:2079-83
111. Ll opez-Sagaseta J, Sibener LV, Kung JE, Gumperz J, Adams EJ. 2012. Lysophospholipid presentation by CD1d and recognition by a human natural killer T-cell receptor. EMBO J. 31:2047.59
112. Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, et al. 2011. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killerTcells. Immunity 34:327.39
113. Aspeslagh S, Li Y, Yu ED, Pauwels N, Trappeniers M, et al. 2011. Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J. 30:2294.305
114. Wun KS, Ross F, Patel O, Besra GS, Porcelli SA, et al. 2012. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex. J. Biol. Chem. 287:39139.48
115. Li Y, Girardi E,Wang J, Yu ED, Painter GF, et al. 2010. The Va14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J. Exp. Med. 207:2383.93
116. Girardi E, Yu ED, Li Y, Tarumoto N, Pei B, et al. 2011. Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells. PLOS Biol. 9:e1001189
117. Patel O, Pellicci DG, Gras S, Sandoval-Romero ML, Uldrich AP, et al. 2012. Recognition of CD1dsulfatide mediated by a type II natural killer T cell antigen receptor. Nat. Immunol. 13:857.63
118. Girardi E, Maricic I, Wang J, Mac T-T, Iyer P, et al. 2012. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens. Nat. Immunol. 13:851.56
119. AdamsEJ, Chien YH, Garcia KC. 2005. Structure of a γδTcell receptor in complex with the nonclassical MHC T22. Science 308:227.31
120. Uldrich AP, Le Nours J, Pellicci DG, Gherardin NA, McPherson KG, et al. 2013. CD1d-lipid antigen recognition by the γδ TCR. Nat. Immunol. 14:1137.45
121. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J,Meehan B, et al. 2012. MR1 presentsmicrobial vitamin B metabolites to MAIT cells. Nature 491:717.23
122. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, et al. 2013. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat. Commun. 4:2142
123. Ll opez-Sagaseta J, Dulberger CL, Crooks JE, Parks CD, Luoma AM, et al. 2013. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins. PNAS 110:E1771.78
124. Ll opez-Sagaseta J, Dulberger CL, McFedries A, Cushman M, Saghatelian A, Adams EJ. 2013. MAIT recognition of a stimulatory bacterial antigen bound to MR1. J. Immunol. 191:5268.77
125. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, et al. 2013. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 210:2305.20
126. Reantragoon R, Kjer-Nielsen L, Patel O, Chen Z, Illing PT, et al. 2012. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med. 209:761.74
127. Eckle S, Birkinshaw R. 2014. A molecular basis underpinning the T cell receptor heterogeneity of Mucosal-Associated Invariant T cells. J. Exp. Med. 211:1585.600
128. Corbett AJ, Eckle SB, Birkinshaw RW, Liu L, Patel O, et al. 2014. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509:361.65
129. Tikhonova AN, Vann Laethem F, Hanada K-I, Lu J, Pobezinsky LA, et al. 2012. αβ T cell receptors that do not undergo major histocompatibility complex-specific thymic selection possess antibody-like recognition specificities. Immunity 36:79.91
130. Yin L, Huseby E, Scott-Browne J, Rubtsova K, Pinilla C, et al. 2011. A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers. Immunity 35:23.33
131. Turner SJ, Kedzierska K, Komodromou H, La GrutaNL, Dunstone MA, et al. 2005. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat. Immunol. 6:382.89
132. Day EB, Guillonneau C, Gras S, La Gruta NL, Vignali DAA, et al. 2011. Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses. PNAS 108:9536.41
133. Auphan-Anezin N, Mazza C, Guimezanes A, Barrett-Wilt GA, Montero-Julian F, et al. 2006. Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/ MHC complexes. Eur. J. Immunol. 36:1856.66
134. Khan AR, Baker BM, Ghosh P, Biddison WE, Wiley DC. 2000. The structure and stability of an HLA-A∗0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site. J. Immunol. 164:6398-405
135. Scott DR, Borbulevych OY, Piepenbrink KH, Corcelli SA, Baker BM. 2011. Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. J. Mol. Biol. 414:385-400
136. Zhao R, Loftus DJ, Appella E, Collins EJ. 1999. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J. Exp. Med. 189:359-70
137. Buslepp J,WangH, BiddisonWE, Appella E, Collins EJ. 2003. A correlation between TCR Vαdocking on MHC and CD8 dependence: implications for T cell selection. Immunity 19:595-606
138. Tynan FE, Borg NA, Miles JJ, Beddoe T, El-Hassen D, et al. 2005. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 280:23900-9
139. Maenaka K, Maenaka T, Tomiyama H, Takiguchi M, Stuart DI, Jones EY. 2000. Nonstandard peptide binding revealed by crystal structures of HLA-B∗5101 complexed withHIV immunodominant epitopes. J. Immunol. 165:3260-67
140. YinL,Crawford F,Marrack P, Kappler JW,Dai S. 2012. T-cell receptor (TCR) interactionwith peptides that mimic nickel offers insight into nickel contact allergy. PNAS 109:18517-22
141. Liu X,Dai S, Crawford F, Fruge R, Marrack P, Kappler J. 2002. Alternate interactions define the binding of peptides to the MHC molecule IAb. PNAS 99:8820-25
142. Yoshida K, Corper AL, Herro R, Jabri B, Wilson IA, Teyton L. 2010. The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity. J. Clin. Investig. 120:1578-90
143. Newell EW, Ely LK, Kruse AC, Reay PA, Rodriguez SN, et al. 2011. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-Ek. J. Immunol. 186:5823-32
144. Hare BJ, Wyss DF, Osburne MS, Kern PS, Reinherz EL, Wagner G. 1999. Structure, specificity and CDR mobility of a class II restricted single-chain T-cell receptor. Nat. Struct. Biol. 6:574-81
145. Zajonc DM, Cantu C 3rd,Mattner J, Zhou D, Savage PB, et al. 2005. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6:810-18
146. Zajonc DM, Savage PB, Bendelac A, Wilson IA, Teyton L. 2008. Crystal structures of mouse CD1diGb3 complex and its cognate Vα14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J. Mol. Biol. 377:1104-16
147. Tyznik AJ, Farber E, Girardi E, Birkholz A, Li Y, et al. 2011. Glycolipids that elicit IFN-γ-biased responses from natural killer T cells. Chem. Biol. 18:1620-30
148. Kjer-Nielsen L, BorgNA, Pellicci DG, Beddoe T, Kostenko L, et al. 2006. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203:661-73
149. Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, et al. 2005. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. 6:819-26
150. Zajonc DM, Maricic I, Wu D, Halder R, Roy K, et al. 2005. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202:1517-26